BowFlex Recalls 3.8 Million Dumbbells After Injury Reports
By I. Edwards HealthDay Reporter
TUESDAY, June 10, 2025 — BowFlex, a fitness equipment brand, is recalling more than 3.8 million adjustable dumbbells because their weight plates can fall off and hurt users.
The recall follows more than 100 reports of injuries, including concussions, broken toes, bruises and scrapes, according to the U.S. Consumer Product Safety Commission (CPSC).
The recalled weights are popular because they allow users to switch between different weights without needing a full rack of dumbbells. But the CPSC says the adjustable design may pose a safety hazard.
The recalled units include 3.7 million sets sold by Nautilus Inc., which changed its name to BowFlex in 2023, CBS News reported.
BowFlex filed for bankruptcy in March 2024. Some of its assets, including the recalled dumbbells, were bought by Johnson Health Tech Retail, which is handling the recall.
"A proactive and broad initiation of this voluntary recall is consistent with our fundamental mission to serve consumers with high-quality and durable fitness equipment," Johnson Health Tech Trading said in a statement.
The recall involves two models:
BowFlex 552, 52.5-lb Adjustable Dumbbells
BowFlex 1090, 90-lb Adjustable Dumbbells
Consumers who bought the dumbbells from Johnson Health Tech Trading may be eligible for a refund or replacement.
If they were bought from BowFlex (formerly Nautilus), a prorated voucher can be requested instead. Consumers will also be eligible for a free one-year digital fitness membership. The company said it is contacting affected customers directly.
But not everyone is satisfied with the recall response.
"Consumers should be able to receive their money back in full, no strings attached," Gabe Knight, a senior policy analyst with Consumer Reports, told CBS News.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-11 06:00
Read more

- Prevalence of Disability Up Over Twofold for Current Smokers
- FDA Authorizes First AI Platform for Breast Cancer Prediction
- Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis
- Lipoprotein(a) Levels Tied to Increased Risk of Recurrent Atherosclerotic CVD Events
- Physical Activity Linked to Better Survival for Specific Cancer Types
- Racial Disparities Driving Emergency Surgery Costs
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions